Abstract
1680 participants were randomized over the recruitment period in MAPT study. A total of 1290 participants were recruited in the 7 University Hospital centers, and 390 participants in the 6 memory clinics around Toulouse Gerontopole / Alzheimer Disease research clinical center. The first randomization was on May 30, 2008, and the targeted number of randomized participants was reached on February 24, 2011; 2595 subjects were finally screened, of which 1680 fulfilled the eligibility criteria which represents 64.8%. Approximately, one quarter of screened people refused to participate after the detailed presentation of the study and 4.3% were still interested in participating but missed for unknown reasons the baseline visit even after repeated contacts. Of the 1810 subjects who signed the consent for participating to the study at the baseline visit, 130 (7.1%) were excluded because one of the eligibility criteria was not satisfied. Interestingly, the higher percentage of randomizations compared to screened participants is the personal contact source; almost 85 % of screened participants entered in the study. In an equivalent way, Medias and conferences are efficient recruiting sources to enrol volunteers in the study. Unexpectedly, only about 60% of screened participants from the hospital and GP sources were randomized and 33.2% from health care services. Almost a quarter of the randomized participants come from the hospital outpatients clinics and approximately 20% from public conferences. A total of 1128 contacts yielded to 556 screened volunteers and 345 randomized participants in the coordinating center of Toulouse. Thus, 30 % of contacts were recruited.
Similar content being viewed by others
References
Alzheimer’s disease International. ADI Publication. World Alzheimer’s Report 2009.
Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B; MAPT Study Group. Commentary on “a roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer’s disease. Alzheimers Dement. 2009;5,2:114–121.
Andrieu S, Aboderin I, Baeyens JP, Beard J, Benetos A, Berrut G, Brainin M, Cha HB, Chen LK, Du P, Forette B, Forette F, Franco A, Fratiglioni L, Gillette-Guyonnet S, Gold G, Gomez F, Guimaraes R, Gustafson D, Khachaturian A, Luchsinger J, Mangialasche F, Mathiex-Fortunet H, Michel JP, Richard E, Schneider LS, Solomon A, Vellas B.IAGG workshop: health promotion program on prevention of late onset dementia. J Nutr Health Aging. 2011;15(7):562–575.
Bonk J, A road map for the recruitment and retention of older adult participants for longitudinal studies. Journal of the American Geriatrics Society 2010
Witham M and McMurdo M. How to Get Older People Included in Clinical Studies. Drugs Aging 2007:24: 187–196.
McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C, Jackson S, Gladman J, O’Mahony S, Ali K, Dickinson E, Edison P, Dyer C; on behalf of the Age and Ageing Specialty Group, NIHR, Comprehensive Clinical Research Network. Improving recruitment of older people to research through good practice. Age and ageing 2011; 0: 1–7
Mody L, Miller DK, McGloin JM, Freeman M, Marcantonio ER, Magaziner J, Studenski S. Recruitment and retention of older adults in aging research. J Am Geriatr Soc. 2008;56(12):2340–2348.
Oustric, S. Rouge-Bugat, M-E. Vellas, B. Primary Care Practitioners on the front line of Alzheimer’s Disease Care. J Am Med Dir Assoc. 2011 Oct;12:545–546.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carrie, I., Abellan Van Kan, G., Gillette-Guyonnet, S. et al. Recruitment strategies for preventive trials. The MAPT study (Multidomain Alzheimer Preventive Trial). J Nutr Health Aging 16, 355–359 (2012). https://doi.org/10.1007/s12603-012-0046-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-012-0046-8